Abstract. To clarify the functional characteristics of prolactin (Prl)-producing adenoma cells, the effect of TRH, prostaglandin E1 (PGE1), theophylline, dopamine and dopaminergic antagonists on Prl secretion was examined in vitro in perifused pituitary adenoma tissues obtained at surgery from 8 patients with prolactinoma.
Abstract. To clarify the functional characteristics of prolactin (Prl)-producing adenoma cells, the effect of TRH, prostaglandin E1 (PGE1), theophylline, dopamine and dopaminergic antagonists on Prl secretion was examined in vitro in perifused pituitary adenoma tissues obtained at surgery from 8 patients with prolactinoma.
Perifusion with TRH at a concentration of 10\m=-\6to 10\m=-\5 m resulted in a significant increase in effluent Prl levels in 3 of the 8 adenoma tissues. In the remaining 5 adenomas, TRH produced no effect on Prl release in vitro. On the other hand, PGE1 (10\m=-\5 m) stimulated Prl secretion in 2 of the 4 adenomas examined. Addition of theophylline (5.5 mM) caused a marked increase of effluent Prl levels in all 8 prolactinomas regardless of the reactivity to TRH or PGE1. Dopamine (5 \m=x\10\m=-\7 m) suppressed Prl secretion from adenoma tissue in 5 of 7 patients tested but had no effect in the remaining two adenomas. When perifused simultaneously with dopamine, sulpiride (D2-selective dopamine receptor blocker, 5 \m=x\10\m=-\7m) blocked the inhibitory effect of dopamine on Prl release in 3 of the 4 dopami ne\x=req-\ sensitive prolactinomas. In one adenoma responsive to dopamine but resistant to sulpiride, YM-09151-2 (relatively specific D1-dopamine receptor blocker, 5 \m=x\10\m=-\7 m) antagonized the The perifusion study was then performed by our method, described previously (Chihara et al. 1982) . The perifusion medium, Krebs-Ringer bicarbonate (KRB) containing 0.2% glucose and 0.25% bovine serum albu¬ min was pumped at a constant flow rate of 0.5 ml/min through a chamber in which 10-20 pieces of pituitaryadenomas were packed with Sephadex G-10 gel. The effluent was collected every 5 min on a fraction collector, and stored at -20°C until assayed. By means of a 5-channel peristaltic pump, 4 chambers could be peri¬ fused simultaneously with different test materials as required. Test substances were dissolved in the perifu¬ sion medium equilibrated with 95% 02-5% C02 before use, and introduced into the perifusion system by trans¬ ferring the inlet tube from the reservoir of KRB medium to the test sample, as described previously (Chihara et al. 1982 ).
Synthetic TRH (Takeda Pharmaceutical Co., Osaka, Japan), prostaglandin Ej (PGEi; Ono Co. Ltd., Tolyo, Japan), sulpiride (Fujisawa Co. Ltd., Tokyo, Japan), do¬ pamine hydrochloride and theophylline (Nakarai Chemi¬ cals Co. Ltd., Kyoto, Japan) were purchased from the re¬ spective companies. The Dj-selective dopamine antago- Prl responses to 30 min pulses of TRH, PGEi, and theophylline in perifused andenoma tissues of cases 2, 4, 5 and 7.
Statistical analysis is the same as described in Fig. 1 . (YM 5 "6 m), and dopamine (DA 5x7 10"7 m) in perifused prolactinoma tissues of cases 1, 3, 4 and 5. S and YM were perifused for 30 min, whereas DA was administered alone for 60 min and then for 30 min simultaneously with either S or YM. Statistical analysis is the same as described in Fig. 1 .
In the present study, the effects of dopamine receptor blockers were also examined in combina¬ tion with dopamine perifusion, in order to define the nature of the dopamine receptor in the prolac¬ tinomas. When sulpiride, a D2-selective receptor blocker, was perifused at a concentration of 5 X 10"7M simultaneously with dopamine (5 x 10"7M), the inhibition of Prl release by dopamine was significantly antagonized by this agent in 3 (cases 1, 3 and 5) of the four dopamine-sensitive prolac¬ tinoma tissues ( Fig. 3; Table 2 ). This prevention by sulpiride of dopamine-induced Prl decrease in vitro was in good agreement with the results of the pre-operative study in vivo (Table 1 ). In the adenoma tissues of case 4 which were responsive to dopamine but resistant to sulpiride (Fig. 3) On the other hand, TRH produced a marked increase of effluent Prl levels in 3 of the 8 pro¬ lactinomas examined in the present study. This is consistent with the previous observations by Knazek & Skyler (1976) and by Adams et al. (1979) suggesting an in vitro Prl (Sundberg et al. 1976; Thorner et al. 1980) . PGEj is also known to accumulate intracellular cAMP without accompanying Prl release in normal rat pituitaries (Thorner et al. 1980; Sundberg et al. 1975 (Malarkey et al. 1977) . However, the results of dopamine binding studies using human pro¬ lactinomas are conflicting. Bression et al. (1980) found that human Prl-secreting adenomas have normal dopaminergic binding affinities with the diminished binding sites. Also, Bethea et al. (1982) reported that human Prl-secreting adenoma cells possess dopamine receptors with high affinity and stereoselectivity. In contrast, Cronin et al. (1980) 
